J&J completes tender offer of Cougar Biotechnology

7/6/2009

NEW BRUNSWICK, N.J. Drug maker Johnson & Johnson has completed its tender offer for a Los Angeles-based biotech company.

J&J announced last week that its tender offer for Cougar Biotechnology expired at midnight Thursday, with 84.4% of the outstanding shares of Cougar’s common stock validly tendered and not withdrawn.

The company said that it would also offer to acquire all remaining shares of Cougar by this Thursday.

FDA approves new indication for Novo Nordisk’s Ozempic

Ozempic has been approved to reduce the risk of worsening kidney disease and cardiovascular death in adults with Type 2 diabetes and chronic kidney disease.

Kroger laying off corporate employees, Albertsons downsizes Safeway workforce

Kroger is cutting about 200 employees across three office sites, and Albertsons is laying off more than 150 Safeway corporate workers.

Eos engages all the senses with new launches, category expansions

Inside Beauty spoke to Jamie Sachs, vice president, product marketing and customer innovation at eos, to discuss its new launches.

Costco to raise hourly pay, reaches tentative agreement with union

Costco also is adding vacation time for new employees during their first year and giving workers with 30 years of employment an additional week of time off, per a CNN report.

Cencora announces common share repurchase from WBA

Cencora said it intends to repurchase shares from WBA at the price per share equal to the price in the Rule 144 sale.